297 Followers on Owler

Aura Biosciences

Aura Biosciences is a Massachusetts-based biotechnology company that researches and develops viral nanoparticle conjugates for the treatment of cancer. Read more

Elisabet de los Pinos's photo - Founder & CEO of Aura Biosciences

Founder & CEO

Elisabet de los Pinos

CEO Approval Rating

84/100

Founded:

2009

Status:

PrivateIndependent Company

AURA BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

TScan is Aura Biosciences's top competitor. TScan was founded in 2018 in Waltham, Massachusetts. TScan competes in the Biotechnology field. TScan generates $4.5M less revenue than Aura Biosciences.

Tmunity is perceived as one of Aura Biosciences's biggest rivals. Tmunity's headquarters is in Philadelphia, Pennsylvania, and was founded in 2015. Like Aura Biosciences, Tmunity also competes in the Biotechnology industry. Tmunity generates 23% of Aura Biosciences's revenue.

Dynavax is one of Aura Biosciences's top competitors. Dynavax is a Public company that was founded in Emeryville, California in 1996. Like Aura Biosciences, Dynavax also competes in the Biotechnology field. Dynavax has 210 more employees vs. Aura Biosciences.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is VelosBio a competitor of Aura Biosciences?

Aura Biosciences Acquisitions

No recent acquisitions found related to Aura Biosciences

Aura Biosciences Funding History

Since Aura Biosciences was founded in 2009, it has participated in 11 rounds of funding. In total Aura Biosciences has raised $197.7M. Aura Biosciences' last funding round was on Mar 2021 for a total of $80.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Equity Round
Mar 2021
$80M

Matrix Capital Management

Venture Round
Jun 2020
$10M
Series D
Mar 2019
$20M
Series C
Dec 2017
$42.3M
Debt
Sep 2016
$11.5M

Since Aura Biosciences was founded in 2009, it has participated in 11 rounds of funding. In total Aura Biosciences has raised $197.7M. Aura Biosciences' last funding round was on Mar 2021 for a total of $80.0M

Aura Biosciences Investments

No recent investments found related to Aura Biosciences

Aura Biosciences News

January 5, 2021MarketScreener

Appoints David Johnson to Its Board of Directors

(marketscreener.com) Aura Biosciences, a clinical-stage oncology company developing a novel class of ... See more »
June 12, 2020FE Investegate

Aura presents updated AU-011 clinical data at ARVO 2020

2:24 PM: (ARIX) Aura presents updated AU-011 clinical data at ARVO 2020... See more »
February 24, 2020BioPortfolio

Aura Biosciences Presents Updated Phase 1b2 Clinical Data for AU011 at the 43rd Annual Macula Society Meeting

LightActivated AU011 Holds Significant Potential as a First Line Treatment for Choroidal MelanomaAura... See more »
September 27, 2019BioPortfolio

Aura Biosciences Announces Clinical Data Presentations at the Upcoming American Academy of Ophthalmology 2019 Annual Meeting

Phase1b2 Clinical Data for Auras Lead Asset AU011 to be Highlighted at the Meeting and at Other Relat... See more »

Aura Biosciences Press Releases

March 21, 2019Business Wire

Aura Biosciences to Present Interim Phase 1b/2 Clinical Data for AU-011 at the International Society of Ocular Oncology 2019 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a leader in the development of novel targeted th... See more »
May 10, 2016Business Wire

Aura Biosciences, Novartis, Pfizer - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Uveal Melanoma - Pip... See more »
December 8, 2015Business Wire

Uveal Melanoma - Pipeline Review, Technologies & Forecasts Report H2 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xssp56/uvea... See more »
September 30, 2015BUSINESS WIRE

Aura Biosciences Forms Clinical Advisory Board in Ocular Oncology and Strengthens Clinical Team to Prepare for Clinical Development of Lead Program in Ocular Melanoma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a biotechnology company developing a new class o... See more »
September 21, 2015BUSINESS WIRE

Aura Biosciences Announces Publication Describing Selective Binding of Viral-like Particles to Cancer Cells

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a biotechnology company developing a new class o... See more »
June 22, 2015BUSINESS WIRE

Metastatic Ovarian Cancer Therapeutics Pipeline Review, H1 2015 - 8 Companies & 12 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fnsss4/meta... See more »
May 21, 2015BUSINESS WIRE

FDA Grants Orphan Drug Designation to Aura Biosciences' Novel Treatment for Uveal Melanoma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences releases in vivo pre-clinical data and announces ... See more »

Aura Biosciences Videos

Social Media

Aura Biosciences Headquarters

85 Bolton Street

Cambridge, Massachusetts02140

617-500-8864

Driving Directions »

Trending Companies

Aura Biosciences Summary

ABOUT

Overview

Aura Biosciences is a Massachusetts-based biotechnology company that researches and develops viral nanoparticle conjugates for the treatment of cancer. Aura Biosciences was founded in 2009. Aura Biosciences' headquarters is located in Cambridge, Massa...

CEO

Aura Biosciences's Founder & CEO, Elisabet de los Pinos, currently has an approval rating of 84%. Aura Biosciences's primary competitors are TScan, Tmunity & Dynavax.

Frequently Asked Questions about Aura Biosciences

  1. When was Aura Biosciences founded?

    Aura Biosciences was founded in 2009
  2. Who is Aura Biosciences's CEO?

    Aura Biosciences's CEO is Elisabet de los Pinos
  3. How much revenue does Aura Biosciences generate?

    Aura Biosciences generates $5.6M in revenue
  4. How much funding does Aura Biosciences have?

    Aura Biosciences has historically raised $197.7M in funding
  1. Where is Aura Biosciences's headquarters?

    Aura Biosciences's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Aura Biosciences have?

    Aura Biosciences has 35 employees
  3. What sector does Aura Biosciences operate in?

    Aura Biosciences is in Biotechnology, Pharmaceuticals
  4. Who are Aura Biosciences's competitors?

    Aura Biosciences's top competitors are TScan, Tmunity, Dynavax